形状感知机器人支气管镜联合移动锥形束CT用于小肺结节的诊断:CONFIRM前瞻性多中心研究
CONFIRM研究为前瞻性多中心观察研究,纳入155例≤20 mm疑似恶性周围肺结节患者,评估ssRAB联合mCBCT的tool-in-lesion、诊断率、恶性灵敏度和安全性。结果显示tool-in-lesion达99.4%,诊断率89.0%,恶性灵敏度91.5%,无气胸发生,仅2例Nashville 3级出血。
要点
- ssRAB联合mCBCT对小周围肺结节tool-in-lesion率达99.4%。
- 诊断率89.0%,恶性灵敏度91.5%,安全性良好。
- 无气胸发生,仅1.3%出现Nashville 3级出血。
核心结论
- 首项ssRAB联合mCBCT的前瞻性多中心研究显示,小周围肺结节诊断结局与经胸活检相似,安全性更优。
研究设计与样本
- 前瞻性观察性多中心研究,纳入155例≤20 mm疑似恶性周围肺结节患者,非恶性索引活检随访12个月。
主要发现
- tool-in-lesion达154/155(99.4%,95%CI 96.5-100.0)。
- 中位mCBCT旋转次数2次(IQR 1-3),中位剂量面积乘积25.7 Gy·cm²(IQR 11.0-46.7)。
- 按ATS/ACCP定义诊断率为89.0%(138/155,95%CI 83.0-93.5),恶性灵敏度91.5%(95%CI 86.4-96.5)。
- 无气胸发生(0%,95%CI 0.0-2.4),2例Nashville 3级出血(1.3%,95%CI 0.2-4.6)。
关键数值与推荐
- tool-in-lesion:154/155(99.4%,95%CI 96.5-100.0)。
- 诊断率(ATS/ACCP定义):89.0%(138/155,95%CI 83.0-93.5)。
- 恶性灵敏度:91.5%(95%CI 86.4-96.5)。
- 气胸发生率:0%(95%CI 0.0-2.4)。
- Nashville 3级出血:2例(1.3%,95%CI 0.2-4.6)。
临床怎么用
- 对于≤20 mm的周围肺结节,可考虑ssRAB联合mCBCT进行活检,以兼顾诊断率与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of 3D imaging with navigation bronchoscopy has increased with the introduction of mobile cone-beam CT (mCBCT). Shape-sensing robotic-assisted bronchoscopy (ssRAB) integrated with mCBCT has been introduced to correct for CT to body divergence (CT-BD) during the biopsy of peripheral pulmonary nodules (PPNs). METHODS: Prospective observational multicentre study, enrolling patients with a PPN of ≤20 mm suspicious for malignancy, assessing tool-in-lesion (TIL), diagnostic yield, sensitivity for malignancy and incidence of pneumothorax or airway bleeding. Non-malignant index biopsies were followed for 12 months. Descriptive statistics are reported for all variables along with 95% CI for primary endpoints. RESULTS: 155 consecutive patients were enrolled at six centres. Median nodule size was 14.0 mm (IQR 11.0-17.0), with 54.8% of nodules (85/155) in the upper lobes, 25.8% (40/155) with CT bronchus sign present and median distance to the nearest pleural surface of 8.2 mm (IQR 1.8-20.0). TIL was achieved in 154/155 (99.4%, 95% CI 96.5 to 100.0) procedures. A median of two (IQR 1-3) mCBCT spins were performed, with median dose area product of 25.7 Gy · cm2 (IQR 11.0-46.7). Diagnostic yield per the American Thoracic Society/American College of Chest Physicians (ATC/ACCP) definition was 89.0% (n=138/155; 95% CI 83.0 to 93.5) and sensitivity for malignancy was 91.5% (95% CI 86.4 to 96.5). No pneumothorax (0%, 95% CI 0.0 to 2.4) and two Nashville Grade three bleeding events were reported (1.3%, 95% CI 0.2 to 4.6). INTERPRETATION: The first prospective multicentre study of integrated ssRAB and mCBCT for small peripheral nodules resulted in diagnostic outcomes similar to those reported for transthoracic biopsy with a more favourable safety profile. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov ID: NCT05562895.
引用
- Husta BC, Cheng GZ, Batra H, et al. Shape-sensing robotic-assisted bronchoscopy with integrated mobile cone-beam CT for small nodules: results from the prospective multicentre CONFIRM study. Thorax. 2026. PMID: 41698810. doi:10.1136/thorax-2025-223272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。